Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all

Thomas E Callis1, Brian C Jensen, Karen E Weck

  • 1PGxHealth Division, Clinical Data, Inc., 5 Science Park, New Haven, CT 06511, USA.

Insights

Familial cardiomyopathies stem from gene mutations and are increasingly diagnosed via genetic testing. This review covers genetic causes, testing utility, and future challenges in diagnosing these heart conditions.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Cardiomyopathies are common, heterogeneous cardiac diseases with significant familial prevalence.
  • Many cardiomyopathies, including hypertrophic, dilated, and arrhythmogenic right ventricular types, follow Mendelian inheritance patterns due to single-gene mutations.
  • The advent of clinical genetic testing necessitates a comprehensive understanding of cardiomyopathy genetics.

Purpose of the Study:

  • To review the genetic underpinnings of selected cardiomyopathies.
  • To describe the clinical utility and application of genetic testing in cardiomyopathy diagnosis.
  • To outline current challenges and emerging advancements in the field of cardiomyopathy genetics and diagnostics.

Main Methods:

  • Literature review focusing on genetic basis of cardiomyopathies.
  • Analysis of clinical utility of genetic testing for familial cardiomyopathies.
  • Synthesis of current challenges and future developments in cardiomyopathy diagnostics.

Main Results:

  • Identified specific gene mutations responsible for various inherited cardiomyopathies.
  • Highlighted the diagnostic and clinical management benefits of genetic testing.
  • Discussed limitations and ongoing progress in genetic diagnostics for cardiomyopathies.

Conclusions:

  • Genetic testing is crucial for diagnosing and managing familial cardiomyopathies.
  • Continued research is needed to address challenges and leverage emerging developments in the field.
  • Understanding genetic etiology improves patient care and family screening for cardiomyopathies.

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...